Litcius/Paper detail

Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection

Myron S. Cohen

2021New England Journal of Medicine89 citationsDOIOpen Access PDF

Abstract

By the end of 2020, more than 19 million Americans had received the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.1 Although a substantial proportion of these ...

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMonoclonal antibodyVirologyMedicineCoronavirusAntibodyImmunologyBetacoronavirusRespiratory systemCoronavirus InfectionsPathologyInternal medicineOutbreakInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing
Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection | Litcius